Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 91 citing articles:

Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Karol Kowalski, Agata Mulak
Journal of Neurogastroenterology and Motility (2019) Vol. 25, Iss. 1, pp. 48-60
Open Access | Times Cited: 641
Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions
Suganya Kanmani, Byung‐Soo Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7551-7551
Open Access | Times Cited: 235
Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
Qiushan Tao, Ting Fang Alvin Ang, Charles DeCarli, et al.
JAMA Network Open (2018) Vol. 1, Iss. 6, pp. e183597-e183597
Open Access | Times Cited: 191
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
Saravana Babu Chidambaram, Musthafa Mohamed Essa, Annan Gopinath Rathipriya, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107988-107988
Open Access | Times Cited: 121
Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
Md. Sahab Uddin, Lee Wei Lim
Ageing Research Reviews (2022) Vol. 78, pp. 101622-101622
Closed Access | Times Cited: 90
Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions
Flaviana Di Lorenzo, Cristina De Castro, Alba Silipo, et al.
FEMS Microbiology Reviews (2019) Vol. 43, Iss. 3, pp. 257-272
Closed Access | Times Cited: 142
Current and emerging avenues for Alzheimer's disease drug targets
Raúl Loera‐Valencia, Ángel Cedazo‐Mínguez, Paul-Ariel Kenigsberg, et al.
Journal of Internal Medicine (2019) Vol. 286, Iss. 4, pp. 398-437
Open Access | Times Cited: 118
Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration
Yuhai Zhao, Walter J. Lukiw
Molecular Neurobiology (2018) Vol. 55, Iss. 12, pp. 9100-9107
Closed Access | Times Cited: 95
Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
Hyeon soo Kim, Sujin Kim, Soo Jung Shin, et al.
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 80
Gut Microbiota: Implications in Alzheimer’s Disease
Yixi He, Binyin Li, Dingya Sun, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 7, pp. 2042-2042
Open Access | Times Cited: 70
The Gut Microbiome as a Regulator of the Neuroimmune Landscape
Lewis W. Yu, Gulistan Agirman, Elaine Y. Hsiao
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 143-167
Open Access | Times Cited: 50
The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
Rawan Tarawneh, Elena Penhos
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104814-104814
Open Access | Times Cited: 49
The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer’s Disease
Benita Wiatrak, Katarzyna Balon, Paulina Jawień, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4862-4862
Open Access | Times Cited: 41
Gastrointestinal syndromes preceding a diagnosis of Parkinson’s disease: testing Braak’s hypothesis using a nationwide database for comparison with Alzheimer’s disease and cerebrovascular diseases
Bo Konings, Luisa Villatoro, Jef Van den Eynde, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2103-2111
Open Access | Times Cited: 28
Levistilide A ameliorates neuroinflammation via inhibiting JAK2/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer’s disease mouse model
H. Ni, Yanfang Liao, Yifan Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110783-110783
Closed Access | Times Cited: 26
Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
Ngoc Minh Nguyen, Jungsook Cho, Choong-Ho Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4047-4047
Open Access | Times Cited: 24
Deciphering the intricate linkage between the gut microbiota and Alzheimer's disease: Elucidating mechanistic pathways promising therapeutic strategies
Junyi Liang, Yueyang Wang, Bin Liu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 8
Re-thinking the Etiological Framework of Neurodegeneration
Ximena Castillo, Susana Castro‐Obregón, Benjamín Gutiérrez-Becker, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 70
Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer’s Disease
Tauqeerunnisa Syeda, Mónica Sánchez‐Tapia, Laura Pinedo-Vargas, et al.
Journal of Alzheimer s Disease (2018) Vol. 66, Iss. 4, pp. 1657-1682
Closed Access | Times Cited: 68
Linking mechanisms of periodontitis to Alzheimer's disease
Mahtab Sadrameli, Praveen Bathini, Lavinia Albéri
Current Opinion in Neurology (2020) Vol. 33, Iss. 2, pp. 230-238
Closed Access | Times Cited: 66
Gastrointestinal (GI) Tract Microbiome-Derived Neurotoxins—Potent Neuro-Inflammatory Signals From the GI Tract via the Systemic Circulation Into the Brain
Walter J. Lukiw
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 63
Exopolysaccharide Isolated from Lactobacillus plantarum L-14 Has Anti-Inflammatory Effects via the Toll-Like Receptor 4 Pathway in LPS-Induced RAW 264.7 Cells
Mijin Kwon, Jaehoon Lee, Sangkyu Park, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9283-9283
Open Access | Times Cited: 63
RETRACTED ARTICLE: Aluminum in Neurological and Neurodegenerative Disease
D. R. Crapper McLachlan, Catherine Bergeron, Peter N. Alexandrov, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 2, pp. 1531-1538
Open Access | Times Cited: 59
Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
Molly Fox, Delaney A. Knorr, Kacey M. Haptonstall
Annals of the New York Academy of Sciences (2019) Vol. 1449, Iss. 1, pp. 3-24
Open Access | Times Cited: 55
Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)
Yuhai Zhao, Vivian Jaber, Aileen I. Pogue, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12671-12671
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top